Werbung
Akari Therapeutics Aktie Analyse
| 08.02.18 | Akari Therapeutics Neutral | B. Riley FBR, Inc. | |
| 31.05.17 | Akari Therapeutics Neutral | Chardan Capital Markets |
Werbung
Werbung